Hepatitis Market Research Reports & Industry Analysis
Hepatitis Industry Research & Market Reports
-
Autoimmune Hepatitis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Adult Vaccine Market Global Forecast Report by Disease wise (Influenza, Cervical Cancer (HPV), Zoster (Shingles), MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, Tdap, Travel and Miscellaneous, Varicella) Countries and Company Analysis, 2024-2032
... Vaccine Market Analysis The global adult vaccine market was valued at US$ 20. 59 billion in 2023 and is projected to reach US$ 35.87 billion by 2032 with the compound annual growth rate of 6.36% ... Read More
-
Viral Hepatitis and Retrovirus Diagnostic Tests
... the year 2023, is expected to reach US$7.7 Billion by 2030, growing at a CAGR of 8.4% over the period 2023-2030. The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow ... Read More
-
Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... Hepatitis B Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Hepatitis B is ... Read More
-
Global Prophylactic Hepatitis B Virus Vaccines Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The main objective of hepatitis B immunization strategies is ... Read More
-
Molecular Diagnostics Market Size, Share & Trends by Product & Services (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH, INAAT), Application (Infectious (Hepatitis, HIV, HAI, TB, HPV), Oncology) - Global Forecast to 2029
... Global Forecast to 2029 The molecular diagnostics market is valued at an estimated USD 17.3 billion in 2024 and is projected to reach USD 32.7 billion by 2029 at a CAGR of 13.5% during the ... Read More
-
Global Travel Vaccines Market Size Study, by Type (Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, Inactive Vaccines, Recombinant Vector Vaccines, Subunit Vaccines, Toxoid Vaccines), by Disease (DPT, Hepatitis A, Hepatitis B, Japanese Encephalitis, Measles and Mumps, Meningococcal, Rabies, Typhoid, Varicella, Yellow Fever), and Regional Forecasts 2024-2032
... Meningococcal, Rabies, Typhoid, Varicella, Yellow Fever), and Regional Forecasts 2024-2032 Global Travel Vaccines Market is valued at approximately USD 8.26 billion in 2023 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Global Antiviral Therapeutics Market Size Study, By Drug (Hepatitis, Herpes, HIV, Influenza), By Therapy (DNA Polymerase Inhibitors, Neuraminidase Inhibitors, Protease Inhibitors, Reverse Transcriptase Inhibitors), By Distribution Channel (Hospital Pharmacy, Independent Pharmacy & Drug Store, Online Pharmacy), and Regional Forecasts 2022-2032
... Pharmacy), and Regional Forecasts 2022-2032 The Global Antiviral Therapeutics Market is valued approximately at USD 75.53 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.28% over the ... Read More
-
DNA Diagnostics Market Size, Share & Trends by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Global Forecast to 2029
... 2029 The global DNA diagnostics market is valued at an estimated USD 13.3 billion in 2024 and is projected to reach USD 21.2 billion by 2029, at a CAGR of 9.7% during the forecast period. ... Read More
-
Anti-Viral Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Branded, Generics), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others) By Region and Competition, 2019-2029F
... Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others) By Region and Competition, 2019-2029F Global Anti Viral Drugs Market has valued at USD 76.01 billion in 2023 and is anticipated to project ... Read More
-
North America Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Country 2024-2032
... North America travel vaccines market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032. ... Read More
-
Hepatitis C Treatment
... by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. HCV Protease Inhibitors Drug Class, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
US Oral Antiviral Market Size study, by Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, Others) by Drug Class (Protease inhibitors, Reverse transcriptase inhibitors, Others) by Distribution Channel (Hospital pharmacies, Drug store and retail pharmacies, Online providers) Forecasts 2022-2032
... providers) Forecasts 2022-2032 US Oral Antiviral Market is valued approximately USD 9.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 1.69% over the forecast period 2024-2032. Oral ... Read More
-
2024 Global: Hepatitis C Virus (Hcv) Testing Market - Innovative Markets Forecast (2030) report
... and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions ... Read More
-
Global Hepatitis B Therapeutics Market 2024-2028
... hepatitis B therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
... qualitative market trends within In Vitro Diagnostics therapeutic area. Hepatitis B is a viral infection that is transmitted through contact with the blood or other body fluids of an infected person. The HBV virus affects ... Read More
-
Global Hepatitis B Vaccines Competitive Landscape Professional Research Report 2024
... The vaccines work by stimulating the immune system to produce antibodies that provide immunity to the virus. Hepatitis B is commonly transmitted through contact with infected blood, unprotected sexual activity, or from an infected mother ... Read More
-
Travel Vaccines Market by Type (Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines), Disease (DPT, Hepatitis A, Hepatitis B) - Global Forecast 2024-2030
... expected to reach USD 9.09 billion in 2024, at a CAGR 10.06% to reach USD 16.18 billion by 2030. The travel vaccines market encompasses the production, distribution, and administration of immunizations recommended or required for ... Read More
-
RNA Interference Technology Market by Type (dsRNA, miRNA, siRNA), Therapeutics (Autoimmune Hepatitis, Hepatitis B and C, Neurological Disorders), Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 39.25 billion in 2024, at a CAGR 22.38% to reach USD 135.40 billion by 2030. The RNA interference (RNAi) technology market encompasses systems that use small RNA molecules ... Read More
-
Hepatitis Drugs Markets in China
... maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, ... Read More
-
Hepatitis Drugs Companies in China
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Hepatitis Drugs Industry Forecasts - China Focus
... manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China ... Read More
-
Autoimmune Hepatitis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Autoimmune Hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Autoimmune Hepatitis market report provides current treatment practices, emerging drugs, Autoimmune ... Read More
-
Hepatitis B – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Hepatitis B market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Hepatitis B market report provides current treatment practices, emerging drugs, Hepatitis ... Read More
-
Chronic Hepatitis Delta Virus (HDV) Infection – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the Chronic Hepatitis Delta Virus (HDV) Infection, historical and forecasted epidemiology as well as the Chronic Hepatitis Delta Virus (HDV) Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
Research Assistance
